phase readout
saveNCT05060627: Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
ACTIVE_NOT_RECRUITINGupdated 1h ago
community read0 votes
Sponsor: PETHEMA Foundation. Phase: PHASE1. Conditions: Relapsed Multiple Myeloma
view source ↗
comments(0)
5-min edit window · permanent after that